News

PsA, Others Join Diabetes as CVD Risk Factors


 

▸ The total cholesterol: HDL cholesterol ratio should be used in the formula for estimating CVD risk.

▸ Interventions with lipid-lowering drugs and with antihypertensive medications should follow national guidelines.

▸ Statins, ACE inhibitors, and angiotensin receptor blockers are the preferred treatment agents because of their pleiotropic effects. Therapy with 40 mg atorvastatin daily in patients with RA was shown to produce a modest but significant improvement in RA disease activity (Lancet 2004;363:2015-21).

▸ The role of cyclooxygenase-2 selective inhibitors (coxibs) and most NSAIDs in most CVD is not well established and needs further investigation; therefore, these agents should be prescribed with caution.

▸ When corticosteroids are prescribed, they should be at the lowest dose possible.

Dr. Nurmohamed reported having no financial conflicts.

Pages

Recommended Reading

Add Vascular Disease to List of Psoriasis Risks
MDedge Dermatology
New Scleroderma-Modifying Therapies Emerging
MDedge Dermatology
Skin Changes Help Identify Scleroderma Mimics
MDedge Dermatology
Skin Elasticity May Serve as Potential Biomarker for Sclerosis
MDedge Dermatology
Acitretin Plus Diabetes Drug May Calm Psoriasis
MDedge Dermatology
Coal Tar Found as Effective as Tazarotene for Psoriasis
MDedge Dermatology
Stem Cells, Skin Substitute Heal Scleroderma Wounds
MDedge Dermatology
Systemic Sclerosis Patients May Need Higher Doses of Vit. D
MDedge Dermatology
Cause of Mortality in Two Psoriasis Studies Conflict
MDedge Dermatology
Beer Consumption Found to Boost Psoriasis Risk
MDedge Dermatology